Immunoglobulin E ( IgE ) is a type of antibody (or immunoglobulin (Ig) " isoform ") that has been found only in mammals . IgE is synthesised by plasma cells . Monomers of IgE consist of two heavy chains (ε chain) and two light chains, with the ε chain containing four Ig-like constant domains (Cε1–Cε4). IgE is thought to be an important part of the immune response against infection by certain parasitic worms , including Schistosoma mansoni , Trichinella spiralis , and Fasciola hepatica . IgE is also utilized during immune defense against certain protozoan parasites such as Plasmodium falciparum . IgE may have evolved as a defense to protect against venoms.
42-448: IgE also has an essential role in type I hypersensitivity , which manifests in various allergic diseases, such as allergic asthma , most types of sinusitis , allergic rhinitis , food allergies, and specific types of chronic urticaria and atopic dermatitis . IgE also plays a pivotal role in responses to allergens, such as anaphylactic reactions to drugs, bee stings, and antigen preparations used in desensitization immunotherapy . IgE
84-579: A different 3D structure and are significantly larger than secreted PLA 2 (more than 700 residues). They include a C2 domain and a large catalytic domain. These phospholipases are involved in cell signaling processes, such as inflammatory response . They release arachidonic acid from membrane phospholipids. Arachidonic acid is both a signaling molecule and the precursor for the synthesis of other signaling molecules termed eicosanoids . These include leukotrienes and prostaglandins . Some eicosanoids are synthesized from diacylglycerol , released from
126-467: A much larger, fatal dose" and "this kind of venom-specific, IgE-associated, adaptive immune response developed, at least in evolutionary terms, to protect the host against potentially toxic amounts of venom, such as would happen if the animal encountered a whole nest of bees, or in the event of a snakebite". The major allergen of bee venom ( phospholipase A2 ) induces a T h 2 immune responses, associated with production of IgE antibodies, which may "increase
168-464: A normal infectious immune response and a type 1 hypersensitivity response is that in type 1 hypersensitivity, the antibody is IgE instead of IgA , IgG , or IgM . During sensitization , the IgE antibodies bind to FcεRI receptors on the surface of tissue mast cells and blood basophils . Mast cells and basophils coated by IgE antibodies are "sensitized". Later exposure to the same allergen cross-links
210-574: A pharmaceutical approach to treatment of several disorders associated with neural trauma. Increase in phospholipase A 2 activity is an acute-phase reaction that rises during inflammation, which is also seen to be exponentially higher in low back disc herniations compared to rheumatoid arthritis . It is a mixture of inflammation and substance P that are responsible for pain. Increased phospholipase A 2 has also been associated with neuropsychiatric disorders such as schizophrenia and pervasive developmental disorders (such as autism ), though
252-408: A recent study, which was performed based on pooled analysis using comprehensive data from 67 phase I to IV clinical trials of omalizumab in various indications, concluded that a causal relationship between omalizumab therapy and malignancy is unlikely. Atopic individuals can have up to ten times the normal level of IgE in their blood (as do sufferers of hyper-IgE syndrome ). However, this may not be
294-657: A requirement for symptoms to occur as has been seen in asthmatics with normal IgE levels in their blood—recent research has shown that IgE production can occur locally in the nasal mucosa. IgE that can specifically recognise an allergen (typically this is a protein, such as dust mite Der p 1 , cat Fel d 1 , grass or ragweed pollen, food protein, etc.) has a unique long-lived interaction with its high-affinity receptor FcεRI so that basophils and mast cells , capable of mediating inflammatory reactions, become "primed", ready to release chemicals like histamine , leukotrienes , and certain interleukins. These chemicals cause many of
336-482: A similar approach to inhibit binding of IgE to its receptor. Type I hypersensitivity Type I hypersensitivity (or immediate hypersensitivity ), in the Gell and Coombs classification of allergic reactions, is an allergic reaction provoked by re-exposure to a specific type of antigen referred to as an allergen . Type I is distinct from type II , type III and type IV hypersensitivities. The relevance of
378-1018: A snake or insect bite, arachidonic acid is released from the phospholipid membrane disproportionately. As a result, inflammation and pain occur at the site. There are also prokaryotic A 2 phospholipases . Additional types of phospholipases include phospholipase A 1 , phospholipase B , phospholipase C , and phospholipase D . Phospholipases A 2 include several unrelated protein families with common enzymatic activity. Two most notable families are secreted and cytosolic phospholipases A 2 . Other families include Ca independent PLA 2 (iPLA 2 ) and lipoprotein-associated PLA 2 (Lp-PLA 2 ), also known as platelet activating factor acetylhydrolase (PAF-AH). The extracellular forms of phospholipases A 2 have been isolated from different venoms ( snake , bee , and wasp ), and from virtually every studied mammalian tissue (including pancreas and kidney ) as well as from bacteria . They require Ca for activity. Pancreatic sPLA 2 serve for
420-478: Is always expressed on B cells ; but IL-4 can induce its expression on the surfaces of macrophages, eosinophils, platelets, and some T cells . The IgE isotype has co-evolved with basophils and mast cells in the defence against parasites like helminths (like Schistosoma) but may be also effective in bacterial infections. Epidemiological research shows that IgE level is increased when infected by Schistosoma mansoni , Necator americanus , and nematodes in humans. It
462-603: Is analogous to neurological diseases such as Alzheimer's disease , epilepsy , multiple sclerosis , ischemia . Lysophospholipids are another class of molecules released from the membrane that are upstream predecessors of platelet activating factors (PAF). Abnormal levels of potent PAF are also associated with neurological damage. An optimal enzyme inhibitor would specifically target PLA 2 activity on neural cell membranes already under oxidative stress and potent inflammation . Thus, specific inhibitors of brain PLA 2 could be
SECTION 10
#1732781055196504-477: Is characterized as the degradation of the tetrahedral intermediate composed of a calcium coordinated oxyanion . The role of calcium can also be duplicated by other relatively small cations like cobalt and nickel. Before becoming active in digestion, the proform of PLA 2 is activated by trypsin. PLA 2 can also be characterized as having a channel featuring a hydrophobic wall in which hydrophobic amino acid residues such as Phe , Leu , and Tyr serve to bind
546-674: Is in phase IIb clinical trial. In 2002, researchers at the Randall Division of Cell and Molecular Biophysics determined the structure of IgE. Understanding of this structure (which is atypical of other isotypes in that it is highly bent and asymmetric) and of the interaction of IgE with receptor FcεRI will enable development of a new generation of allergy drugs that seek to interfere with the IgE-receptor interaction. It may be possible to design treatments cheaper than monoclonal antibodies (for instance, small molecule drugs) that use
588-448: Is modified into active compounds called eicosanoids . Eicosanoids include prostaglandins and leukotrienes , which are categorized as anti-inflammatory and inflammatory mediators. PLA 2 enzymes are commonly found in mammalian tissues as well as arachnid, insect, and snake venom. Venom from bees is largely composed of melittin , which is a stimulant of PLA 2 . Due to the increased presence and activity of PLA 2 resulting from
630-551: Is most likely beneficial in removal of hookworms from the lung. In 1981 Margie Profet suggested that allergic reactions have evolved as a last line of defense to protect against venoms . Although controversial at the time, new work supports some of Profet’s thoughts on the adaptive role of allergies as a defense against noxious toxins. In 2013 it emerged that IgE-antibodies play an essential role in acquired resistance to honey bee and Russell's viper venoms. The authors concluded that "a small dose of bee venom conferred immunity to
672-763: Is observed in the cerebrospinal fluid of humans with Alzheimer's disease and multiple sclerosis , and may serve as a marker of increases in permeability of the blood-cerebrospinal fluid barrier . There are atypical members of the phospholipase A 2 family, such as PLA2G12B , that have no phospholipase activity with typical phospholipase substrate. The lack of enzymatic activity of PLA2G12B indicates that it may have unique function distinctive from other sPLA 2 . It has been shown that in PLA2G12B null mice, VLDL levels were greatly reduced, suggesting it could have an effect in lipoprotein secretion. The intracellular , group IV PLA 2 are also Ca-dependent, but they have
714-399: Is phosphorylated by a MAPK at Serine -505. When phosphorylation is coupled with an influx of calcium ions, cPLA 2 becomes stimulated and can translocate to the membrane to begin catalysis . Phosphorylation of cPLA 2 may be a result of ligand binding to receptors, including: In the case of an inflammation, the application of glucocorticoids up-regulate (mediated at the gene level)
756-527: Is theorized to be of pathogenetic importance in SLE and RA by eliciting a hypersensitivity reaction. Regulation of IgE levels through control of B cell differentiation to antibody-secreting plasma cells is thought to involve the "low-affinity" receptor FcεRII, or CD23 . CD23 may also allow facilitated antigen presentation, an IgE-dependent mechanism whereby B cells expressing CD23 are able to present allergen to (and stimulate) specific T helper cells , causing
798-529: Is typically the least abundant isotype: blood serum IgE levels in a non- atopic individual are only 0.05% of the Ig concentration, compared to 75% for the IgGs at 10 mg/ml. Despite this, it is capable of triggering anaphylaxis , one of the most rapid and severe immunological reactions. IgE was simultaneously discovered in 1966 and 1967 by two independent groups: by Kimishige Ishizaka and his wife Teruko Ishizaka at
840-634: The degranulation of mast cells that is normally triggered by IgE-binding at FcεRI . Long-term uses of systemic corticosteroids are known to cause many serious side effects and are advisable to avoid, if alternative therapies are available. IgE, the IgE synthesis pathway, and the IgE-mediated allergic/inflammatory pathway are all important targets in intervening with the pathological processes of allergy, asthma, and other IgE-mediated diseases. The B lymphocyte differentiation and maturation pathway that eventually generate IgE-secreting plasma cells go through
882-426: The lipid bilayer by phospholipase C (see below). Phospholipases A 2 can be classified based on sequence homology. Increased levels of Lp-PLA 2 are associated with cardiac disease, and may contribute to atherosclerosis . However, the role of Lp-PLA 2 in atherosclerosis may depend on its carrier in plasma, and several lines of evidence suggest that HDL-associated Lp-PLA 2 may substantially contribute to
SECTION 20
#1732781055196924-720: The Children's Asthma Research Institute and Hospital in Denver , Colorado , and by Gunnar Johansson and Hans Bennich [ sv ] in Uppsala , Sweden . Their joint paper was published in April 1969. IgE primes the IgE-mediated allergic response by binding to Fc receptors found on the surface of mast cells and basophils . Fc receptors are also found on eosinophils , monocytes , macrophages and platelets in humans. There are two types of Fcε receptors: IgE can upregulate
966-535: The European Union and the U. S. for treating chronic spontaneous urticaria , which cannot be adequately treated with H1- antihistamines . In the second approach, antibodies specific for a domain of 52 amino acid residues, referred to as CεmX or M1’ (M1 prime), present only on human mIgE on B cells and not on free, soluble IgE, have been prepared and are under clinical development for the treatment of allergy and asthma. An anti-M1’ humanized antibody, quilizumab ,
1008-467: The Gell and Coombs classification of allergic reactions has been questioned in the modern-day understanding of allergy, and it has limited utility in clinical practice. Exposure may be by ingestion , inhalation , injection , or direct contact. In type I hypersensitivity, B cells are stimulated (by CD4 T h 2 cells ) to produce IgE antibodies specific to an antigen. The difference between
1050-512: The HDL antiatherogenic activities. The suggested catalytic mechanism of pancreatic sPLA 2 is initiated by a His-48/Asp-99/calcium complex within the active site. The calcium ion polarizes the sn-2 carbonyl oxygen while also coordinating with a catalytic water molecule, w5. His-48 improves the nucleophilicity of the catalytic water via a bridging second water molecule, w6. It has been suggested that two water molecules are necessary to traverse
1092-503: The IgE pathway were evolved and both are in active development. In the first approach, the anti-IgE antibody drug omalizumab (trade name Xolair ) recognises IgE not bound to its receptors and is used to neutralise or mop-up existing IgE and prevent it from binding to the receptors on mast cells and basophils. Xolair has been approved in many countries for treating severe, persistent allergic asthma. It has also been approved in March 2014 in
1134-708: The bound IgE on sensitized cells, resulting in anaphylactic degranulation , which is the immediate and explosive release of pharmacologically active pre-formed mediators from storage granules and concurrent synthesis of inflammatory lipid mediators from arachidonic acid ; some of these mediators include histamine , leukotriene (LTC4 and LTD4 and LTB4), and prostaglandin , which act on proteins (e.g., G-protein coupled receptors ) located on surrounding tissues. The principal effects of these products are vasodilation and smooth-muscle contraction. Type I hypersensitivity can be further classified into immediate and late-phase reactions. Within minutes of exposure to an antigen,
1176-486: The cleavage of fatty acids in position 2 of phospholipids , hydrolyzing the bond between the second fatty acid "tail" and the glycerol molecule: This particular phospholipase specifically recognizes the sn 2 acyl bond of phospholipids and catalytically hydrolyzes the bond, releasing arachidonic acid and lysophosphatidyl choline , a precursor of lysophosphatidic acid . Upon downstream modification by cyclooxygenases or lipoxygenases , arachidonic acid
1218-405: The distance between the catalytic histidine and the ester . The basicity of His-48 is thought to be enhanced through hydrogen bonding with Asp-99. An asparagine substitution for His-48 maintains wild-type activity, as the amide functional group on asparagine can also function to lower the p K a , or acid dissociation constant , of the bridging water molecule. The rate limiting state
1260-547: The expression of both types of Fcε receptors. FcεRI is expressed on mast cells, basophils, and the antigen-presenting dendritic cells in both mice and humans. Binding of antigens to IgE already bound by the FcεRI on mast cells causes cross-linking of the bound IgE and the aggregation of the underlying FcεRI, leading to degranulation (the release of mediators) and the secretion of several types of type 2 cytokines like interleukin (IL)-3 and stem cell factor (SCF), which both help
1302-408: The following drugs: (1) antihistamines and antileukotrienes , which antagonize the inflammatory mediators histamine and leukotrienes, (2) local or systemic (oral or injectable) corticosteroids , which suppress a broad spectrum of inflammatory mechanisms, (3) short or long-acting bronchodilators , which relax smooth muscle of constricted airway in asthma, or (4) mast cell stabilizers , which inhibit
Immunoglobulin E - Misplaced Pages Continue
1344-684: The formation of fatty acids including arachidonic acid . This arachidonic acid is then metabolized to form several inflammatory and thrombogenic molecules. Excess levels of sPLA 2 is thought to contribute to several inflammatory diseases , and has been shown to promote vascular inflammation correlating with coronary events in coronary artery disease and acute coronary syndrome , and possibly leading to acute respiratory distress syndrome and progression of tonsillitis . In children, excess levels of sPLA 2 have been associated with inflammation thought to exacerbate asthma and ocular surface inflammation ( dry eye ). Increased sPLA 2 activity
1386-407: The immediate hypersensitivity occurs, releasing histamines and lipid mediators which are responsible for the initial allergic reaction response. However, about 4-12 hours after antigen exposure, a cough and wheezing may persist in the patient, along with swelling and redness of the skin. This is known as the late-phase hypersensitivity reaction which can last from approximately 1-3 days and is caused by
1428-445: The initial digestion of phospholipid compounds in dietary fat . Venom phospholipases help to immobilize prey by promoting cell lysis . In mice, group III sPLA 2 are involved in sperm maturation, and group X are thought to be involved in sperm capacitation . sPLA 2 has been shown to promote inflammation in mammals by catalyzing the first step of the arachidonic acid pathway by breaking down phospholipids , resulting in
1470-529: The intermediate steps of IgE-expressing B lymphoblasts and involves the interaction with IgE-expressing memory B cells. Tanox , a biotech company based in Houston, Texas, proposed in 1987 that by targeting membrane-bound IgE (mIgE) on B lymphoblast and memory B cells, those cells can be lysed or down-regulated, thus achieving the inhibition of the production of antigen-specific IgE and hence a shift of immune balance toward non-IgE mechanisms. Two approaches targeting
1512-432: The mast cells survive and accumulate in tissue, and IL-4 , IL-5 , IL-13 , and IL-33 , which in turn activate group 2-innate lymphoid cells ( ILC2 or natural helper cells). Basophils share a common haemopoietic progenitor with mast cells; upon the cross-linking of their surface bound IgE by antigens, also release type 2 cytokines, including IL-4 and IL-13, and other inflammatory mediators. The low-affinity receptor (FcεRII)
1554-568: The perpetuation of a T h 2 response, one of the hallmarks of which is the production of more antibodies. Diagnosis of allergy is most often done by reviewing a person's medical history and finding a positive result for the presence of allergen specific IgE when conducting a skin or blood test. Specific IgE testing is the proven test for allergy detection; evidence does not show that indiscriminate IgE testing or testing for immunoglobulin G (IgG) can support allergy diagnosis. Currently, allergic diseases and asthma are usually treated with one or more of
1596-480: The production of the protein lipocortin which may inhibit cPLA 2 and reduce the inflammatory response. In normal brain cells, PLA 2 regulation accounts for a balance between arachidonic acid 's conversion into proinflammatory mediators and its reincorporation into the membrane. In the absence of strict regulation of PLA 2 activity, a disproportionate amount of proinflammatory mediators are produced. The resulting induced oxidative stress and neuroinflammation
1638-762: The release of additional mediators from the mast cells and basophils. The reaction may be either local or systemic. Symptoms vary from mild irritation to sudden death from anaphylactic shock . If multiple systems are involved, then anaphylaxis can take place, which is an acute, systemic reaction that can prove fatal. Treatment usually involves adrenaline ( epinephrine ) because it counteracts anaphylaxis by increasing blood flow and relaxing bronchial muscles that block one’s airways. Antihistamines and corticosteroids are also commonly used in less severe reactions. Some examples: Phospholipase A2 The enzyme phospholipase A 2 (EC 3.1.1.4, PLA 2 , systematic name phosphatidylcholine 2-acylhydrolase ) catalyses
1680-464: The resistance of mice to challenge with potentially lethal doses". Although it is not yet well understood, IgE may play an important role in the immune system's recognition of cancer , in which the stimulation of a strong cytotoxic response against cells displaying only small amounts of early cancer markers would be beneficial. If this were the case, anti-IgE treatments such as omalizumab (for allergies) might have some undesirable side effects. However,
1722-457: The substrate. Another component of PLA 2 is the seven disulfide bridges that are influential in regulation and stable protein folding. PLA 2 action can release histamine from rat peritoneal mast cells. It also causes histamine release in human basophils. Due to the importance of PLA 2 in inflammatory responses , regulation of the enzyme is essential. cPLA 2 is regulated by phosphorylation and calcium concentrations. cPLA 2
Immunoglobulin E - Misplaced Pages Continue
1764-485: The symptoms we associate with allergy, such as airway constriction in asthma , local inflammation in eczema , increased mucus secretion in allergic rhinitis , and increased vascular permeability, it is presumed, to allow other immune cells to gain access to tissues, but which can lead to a potentially fatal drop in blood pressure as in anaphylaxis . IgE is known to be elevated in various autoimmune disorders such as SLE , rheumatoid arthritis (RA), and psoriasis , and
#195804